EXTENDICARE INC (EXE.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:EXE - CA30224T8639 - Common Stock
22.54 CAD
+0.26 (+1.17%)
We assign a fundamental rating of 6 out of 10 to EXE. EXE was compared to 15 industry peers in the Health Care Providers & Services industry. EXE has an excellent profitability rating, but there are some minor concerns on its financial health. EXE has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
- EXE had positive earnings in the past year.
- EXE had a positive operating cash flow in the past year.
- In the past 5 years EXE has always been profitable.
- Each year in the past 5 years EXE had a positive operating cash flow.
1.2 Ratios
- EXE has a better Return On Assets (10.41%) than 86.67% of its industry peers.
- With an excellent Return On Equity value of 55.53%, EXE belongs to the best of the industry, outperforming 93.33% of the companies in the same industry.
- EXE has a better Return On Invested Capital (18.54%) than 100.00% of its industry peers.
- EXE had an Average Return On Invested Capital over the past 3 years of 11.40%. This is above the industry average of 6.98%.
- The 3 year average ROIC (11.40%) for EXE is below the current ROIC(18.54%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROIC | 18.54% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
1.3 Margins
- EXE has a better Profit Margin (5.72%) than 86.67% of its industry peers.
- In the last couple of years the Profit Margin of EXE has grown nicely.
- With a decent Operating Margin value of 8.22%, EXE is doing good in the industry, outperforming 80.00% of the companies in the same industry.
- In the last couple of years the Operating Margin of EXE has grown nicely.
- EXE has a Gross Margin of 14.15%. This is amonst the worse of the industry: EXE underperforms 80.00% of its industry peers.
- EXE's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% |
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so EXE is creating value.
- Compared to 1 year ago, EXE has more shares outstanding
- EXE has less shares outstanding than it did 5 years ago.
- Compared to 1 year ago, EXE has an improved debt to assets ratio.
2.2 Solvency
- An Altman-Z score of 3.32 indicates that EXE is not in any danger for bankruptcy at the moment.
- EXE has a better Altman-Z score (3.32) than 86.67% of its industry peers.
- The Debt to FCF ratio of EXE is 3.39, which is a good value as it means it would take EXE, 3.39 years of fcf income to pay off all of its debts.
- EXE's Debt to FCF ratio of 3.39 is fine compared to the rest of the industry. EXE outperforms 80.00% of its industry peers.
- A Debt/Equity ratio of 1.94 is on the high side and indicates that EXE has dependencies on debt financing.
- Looking at the Debt to Equity ratio, with a value of 1.94, EXE is doing worse than 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Altman-Z | 3.32 |
ROIC/WACC2.4
WACC7.72%
2.3 Liquidity
- EXE has a Current Ratio of 0.81. This is a bad value and indicates that EXE is not financially healthy enough and could expect problems in meeting its short term obligations.
- With a Current ratio value of 0.81, EXE perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
- A Quick Ratio of 0.81 indicates that EXE may have some problems paying its short term obligations.
- EXE has a better Quick ratio (0.81) than 66.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 52.52% over the past year.
- Measured over the past years, EXE shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.74% on average per year.
- Looking at the last year, EXE shows a quite strong growth in Revenue. The Revenue has grown by 11.59% in the last year.
- Measured over the past years, EXE shows a small growth in Revenue. The Revenue has been growing by 5.31% on average per year.
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
3.2 Future
- Based on estimates for the next years, EXE will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.75% on average per year.
- Based on estimates for the next years, EXE will show a quite strong growth in Revenue. The Revenue will grow by 10.83% on average per year.
EPS Next Y33.67%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 21.67, which indicates a rather expensive current valuation of EXE.
- EXE's Price/Earnings ratio is a bit cheaper when compared to the industry. EXE is cheaper than 73.33% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, EXE is valued a bit cheaper.
- EXE is valuated rather expensively with a Price/Forward Earnings ratio of 19.27.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of EXE indicates a somewhat cheap valuation: EXE is cheaper than 73.33% of the companies listed in the same industry.
- When comparing the Price/Forward Earnings ratio of EXE to the average of the S&P500 Index (24.29), we can say EXE is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.67 | ||
| Fwd PE | 19.27 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, EXE is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXE is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 18.95 | ||
| EV/EBITDA | 12.43 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- EXE has an outstanding profitability rating, which may justify a higher PE ratio.
- EXE's earnings are expected to grow with 19.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.64
PEG (5Y)0.95
EPS Next 2Y21.07%
EPS Next 3Y19.7%
5. Dividend
5.1 Amount
- EXE has a Yearly Dividend Yield of 2.26%.
- EXE's Dividend Yield is a higher than the industry average which is at 1.30.
- EXE's Dividend Yield is a higher than the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
5.2 History
- The dividend of EXE has a limited annual growth rate of 2.79%.
- EXE has paid a dividend for at least 10 years, which is a reliable track record.
- EXE has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)2.79%
Div Incr Years1
Div Non Decr Years3
5.3 Sustainability
- EXE pays out 45.22% of its income as dividend. This is a bit on the high side, but may be sustainable.
- EXE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP45.22%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
TSX:EXE (1/16/2026, 7:00:00 PM)
22.54
+0.26 (+1.17%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-11 2025-11-11
Earnings (Next)02-26 2026-02-26
Inst Owners24.82%
Inst Owner ChangeN/A
Ins Owners0.96%
Ins Owner ChangeN/A
Market Cap1.89B
Revenue(TTM)1.59B
Net Income(TTM)91.00M
Analysts78
Price Target24.69 (9.54%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.26% |
Yearly Dividend0.48
Dividend Growth(5Y)2.79%
DP45.22%
Div Incr Years1
Div Non Decr Years3
Ex-Date01-30 2026-01-30 (0.042)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.12%
PT rev (3m)46.61%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.61%
EPS NY rev (3m)6.94%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.65%
Revenue NY rev (3m)3.84%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.67 | ||
| Fwd PE | 19.27 | ||
| P/S | 1.19 | ||
| P/FCF | 18.95 | ||
| P/OCF | 12.37 | ||
| P/B | 11.53 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.43 |
EPS(TTM)1.04
EY4.61%
EPS(NY)1.17
Fwd EY5.19%
FCF(TTM)1.19
FCFY5.28%
OCF(TTM)1.82
OCFY8.09%
SpS18.97
BVpS1.96
TBVpS-0.41
PEG (NY)0.64
PEG (5Y)0.95
Graham Number6.76
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.41% | ||
| ROE | 55.53% | ||
| ROCE | 24.53% | ||
| ROIC | 18.54% | ||
| ROICexc | 26.92% | ||
| ROICexgc | 58.63% | ||
| OM | 8.22% | ||
| PM (TTM) | 5.72% | ||
| GM | 14.15% | ||
| FCFM | 6.27% |
ROA(3y)8.13%
ROA(5y)6.26%
ROE(3y)56.07%
ROE(5y)44.35%
ROIC(3y)11.4%
ROIC(5y)10.15%
ROICexc(3y)15.38%
ROICexc(5y)13.52%
ROICexgc(3y)24.33%
ROICexgc(5y)19.82%
ROCE(3y)15.09%
ROCE(5y)13.42%
ROICexgc growth 3Y72.34%
ROICexgc growth 5Y37.48%
ROICexc growth 3Y55.61%
ROICexc growth 5Y29.1%
OM growth 3Y21.21%
OM growth 5Y10.26%
PM growth 3Y73.29%
PM growth 5Y15.22%
GM growth 3Y6.44%
GM growth 5Y3.11%
F-Score6
Asset Turnover1.82
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.94 | ||
| Debt/FCF | 3.39 | ||
| Debt/EBITDA | 1.91 | ||
| Cap/Depr | 150.97% | ||
| Cap/Sales | 3.34% | ||
| Interest Coverage | 9.89 | ||
| Cash Conversion | 92.12% | ||
| Profit Quality | 109.55% | ||
| Current Ratio | 0.81 | ||
| Quick Ratio | 0.81 | ||
| Altman-Z | 3.32 |
F-Score6
WACC7.72%
ROIC/WACC2.4
Cap/Depr(3y)281.27%
Cap/Depr(5y)221.87%
Cap/Sales(3y)7.03%
Cap/Sales(5y)5.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)52.52%
EPS 3Y92.12%
EPS 5Y22.74%
EPS Q2Q%65.04%
EPS Next Y33.67%
EPS Next 2Y21.07%
EPS Next 3Y19.7%
EPS Next 5Y9.75%
Revenue 1Y (TTM)11.59%
Revenue growth 3Y7.91%
Revenue growth 5Y5.31%
Sales Q2Q%22.62%
Revenue Next Year15.35%
Revenue Next 2Y25.35%
Revenue Next 3Y18.26%
Revenue Next 5Y10.83%
EBIT growth 1Y30.7%
EBIT growth 3Y30.79%
EBIT growth 5Y16.11%
EBIT Next Year10.8%
EBIT Next 3Y17.11%
EBIT Next 5Y9.15%
FCF growth 1Y199.78%
FCF growth 3YN/A
FCF growth 5Y53.33%
OCF growth 1Y343.54%
OCF growth 3Y31.32%
OCF growth 5Y26.02%
EXTENDICARE INC / EXE.CA FAQ
What is the fundamental rating for EXE stock?
ChartMill assigns a fundamental rating of 6 / 10 to EXE.CA.
What is the valuation status for EXE stock?
ChartMill assigns a valuation rating of 5 / 10 to EXTENDICARE INC (EXE.CA). This can be considered as Fairly Valued.
What is the profitability of EXE stock?
EXTENDICARE INC (EXE.CA) has a profitability rating of 8 / 10.
Can you provide the expected EPS growth for EXE stock?
The Earnings per Share (EPS) of EXTENDICARE INC (EXE.CA) is expected to grow by 33.67% in the next year.
Is the dividend of EXTENDICARE INC sustainable?
The dividend rating of EXTENDICARE INC (EXE.CA) is 6 / 10 and the dividend payout ratio is 45.22%.